Overview

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy in treating children who have relapsed acute lymphoblastic leukemia.
Phase:
Phase 3
Details
Lead Sponsor:
Children's Oncology Group
Collaborator:
National Cancer Institute (NCI)
Treatments:
Asparaginase
BB 1101
Calcium, Dietary
Cobalt
Cortisol succinate
Cytarabine
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Etoposide
Etoposide phosphate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Idarubicin
Ifosfamide
Isophosphamide mustard
Leucovorin
Levoleucovorin
Mesna
Methotrexate
Pegaspargase
Thioguanine
Vincristine